Canaccord Genuity analyst Richard Close maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Tuesday, setting a price target of $39, which is approximately 9.95% above the present share price of $35.47.
Close expects AdaptHealth to post earnings per share (EPS) of -$0.04 for the fourth quarter of 2020.
The current consensus among 7 TipRanks analysts is for a Strong Buy rating of shares in AdaptHealth, with an average price target of $36.36.
The analysts price targets range from a high of $40 to a low of $32.5.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $284.41 million and a net profit of $13.26 million. The company's market cap is $3.18 billion.
According to TipRanks.com, Canaccord Genuity analyst Richard Close is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 26.9% and a 63.61% success rate.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.